Enochian Biosciences Inc. (ENOB)
NASDAQ: ENOB
· Real-Time Price · USD
0.71
0.01 (1.43%)
At close: Aug 04, 2023, 9:58 PM
Enochian Biosciences Balance Sheet Statement
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
Cash & Equivalents | 923K | 311.76K | 220.57K | 220.47K | 243.98B | 1,874.5B | 2.95M | 4.12M | 7.97M | 9.17M | 11.15M | 13.71M | 15.38M | 20.66M | 4.53M | 3.43M | 5.97M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 14.15K | 12.05K | 81.7K | 19.85K | 42,632.7B | 42,632.7B | 58.59K | 61.94K | 65.28K | 68.64K | 21.74K | 31.49K | 20.98K | 20.98K | 30.48K | 30.48K | 137.55K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.64K | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 2.75M | 1.4M | 1.73M | 1.78M | 2,159.2B | 690.92B | 978.88K | 1.27M | 160.63K | 393K | 544.74K | 910.64K | 78.11K | n/a | 394.89K | 583.03K | 99.87K |
Total Current Assets | 3.67M | 1.71M | 1.95M | 2M | 2,403.2B | 2,565.4B | 3.93M | 5.39M | 8.13M | 9.57M | 11.7M | 14.62M | 15.46M | 20.9M | 4.92M | 4.01M | 6.07M |
Property-Plant & Equipment | 1.39M | 1.6M | 1.6M | 1.75M | 1,309.6B | 1,423B | 1.49M | 1.57M | 1.62M | 1.74M | 1.87M | 1.97M | 2.06M | 2.16M | 2.21M | 2.31M | 2.39M |
Goodwill & Intangibles | 112.66M | 108.02M | 118.2M | 159.36M | 11,672.6B | 11,679.7B | 73.25M | 73.25M | 73.25M | 73.26M | 166.51M | 166.52M | 166.52M | 166.53M | 166.53M | 166.54M | 166.54M |
Total Long-Term Assets | 114.06M | 109.63M | 119.88M | 161.13M | 55,615B | 55,735.4B | 74.8M | 74.88M | 74.94M | 75.07M | 168.4M | 168.52M | 168.61M | 168.71M | 168.78M | 168.88M | 169.07M |
Total Assets | 117.73M | 111.34M | 121.83M | 163.13M | 58,018.1B | 58,300.8B | 78.73M | 80.27M | 83.07M | 84.63M | 180.1M | 183.14M | 184.06M | 189.61M | 173.7M | 172.89M | 175.13M |
Account Payables | 11.73M | 10.93M | 11.4M | 9.45M | 5,577.9B | 5,296.8B | 4.47M | 4.56M | 4.68M | 1.4M | 487.02K | 166.75K | 547.87K | 320.56K | 504.86K | 188.92K | 282.38K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 466.32K | 504.38K | n/a | 1.18M | 313.37K | 603.18K | n/a |
Short-Term Debt | 6.53M | 5.69M | 3.11M | 2.94M | 6,727.5B | 4,818.4B | 6.21M | 4.93M | 1.4M | 1.45M | 6.28M | 5.03M | 297.9K | 292.41K | 287.02K | 281.73K | 276.46K |
Other Current Liabilities | 10.58M | 11.98M | 8.52M | 17.92M | 1,453B | 907.91B | 1.09M | 1.81M | 1.08M | 3.6M | 744.03K | 1M | 364.77K | 1.27M | 616.37K | 1.09M | 273.35K |
Total Current Liabilities | 28.84M | 28.61M | 23.04M | 30.31M | 13,758.4B | 11,023.1B | 11.77M | 11.29M | 7.16M | 6.45M | 7.51M | 6.2M | 1.21M | 1.89M | 1.41M | 1.56M | 832.18K |
Long-Term Debt | 497.63K | 674.2K | 710.26K | 842.39K | 664.22B | 775.59B | 829.21K | 2.08M | 5.59M | 5.56M | 1.04M | 2.28M | 7.02M | 7.02M | 7.02M | 7.32M | 7.32M |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 10.31M | 9.03M | 8.86M | 6.04M | 2.95M | 2.07M | 2.76M |
Total Long-Term Liabilities | 497.63K | 674.2K | 710.26K | 842.39K | 664.22B | 775.59B | 829.21K | 2.08M | 5.59M | 5.56M | 11.35M | 11.31M | 15.88M | 13.06M | 9.97M | 9.39M | 10.07M |
Total Liabilities | 29.34M | 29.28M | 23.75M | 31.15M | 14,422.6B | 11,798.7B | 12.6M | 13.37M | 12.75M | 12.01M | 18.86M | 17.52M | 17.09M | 14.94M | 11.38M | 10.94M | 10.9M |
Total Debt | 7.03M | 6.37M | 3.82M | 3.79M | 7,391.7B | 5,594B | 7.04M | 7.01M | 6.99M | 7.02M | 7.32M | 7.32M | 7.31M | 7.31M | 7.31M | 7.6M | 7.59M |
Common Stock | 16.24K | 16.22K | 15.76K | 15.5K | 6.72B | 6.37B | 5.8K | 5.57K | 5.55K | 5.3K | 5.28K | 5.26K | 5.22K | 5.22K | 4.78K | 4.68K | 4.66K |
Retained Earnings | -383.73M | -383.92M | -368.89M | -324.68M | -257,733.4B | -244,029.3B | -220.83M | -216.5M | -212.04M | -204.35M | -114.11M | -107.91M | -101.32M | -90.91M | -73.55M | -69.52M | -66.58M |
Comprehensive Income | 775.61K | -3.85M | 6.3M | -170.85K | -27.23B | -29.88B | -32.38K | -30.27K | -38.19K | -30.44K | -21.49K | -18.82K | -14.83K | -10.83K | -12.92K | -3.09K | -13.03K |
Shareholders Equity | 88.39M | 82.06M | 98.09M | 131.98M | 43,595.5B | 46,502.1B | 66.13M | 66.9M | 70.32M | 72.62M | 161.24M | 165.62M | 166.97M | 174.66M | 162.32M | 161.94M | 164.23M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |